Worldwide Support for Virology Research Announced
Apr 28 2020
In the current urgency to develop vaccines against virus-related diseases, academic institutes and biopharmaceutical companies worldwide rely on the broad product portfolio offered by ibidi. Many publications in reputable scientific journals reflect the importance of ibidi’s ongoing contribution to this research area.
The COVID-19 pandemic, caused by the highly pathogenic SARS-CoV-2 virus, is spreading quickly. Scientists all over the world are intensively working to find solutions to fight this and other viruses - from pathogen detection through therapeutics, to the development of novel vaccines.
For more than 18 years, ibidi has been helping in many areas of virology research, resulting in hundreds of virology-related publications citing ibidi solutions. Researchers can refer to the ibidi Publication Database at ibidi.com to find references for their specific scientific work.
“The research of specific antiviral treatments is urgently needed, and we are working hard to help researchers worldwide advance their therapeutic solutions,” said Dr Roman Zantl, CEO at ibidi. “If you need a specialised product for your research that is not in our portfolio, please contact us and we will gladly collaborate with you.”
More information online
In This Edition Articles - The challenges of Biosample access and what needs to change - Innovative UK exports must gather income - not dust Spotlight Life Sciences - How a Pipettin...
View all digital editions
Sep 27 2021 Virtual event
Sep 27 2021 Beijing, China
Sep 28 2021 Glasgow, Scotland
Sep 29 2021 Online event
Oct 03 2021 Prague, Czech Republic